Mike Matson
Stock Analyst at Needham
(3.15)
# 1,152
Out of 4,712 analysts
459
Total ratings
44.24%
Success rate
0.8%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PSNL Personalis | Reiterates: Buy | $7.25 | $6.09 | +19.05% | 17 | Dec 20, 2024 | |
| HOLX Hologic | Reiterates: Buy | $90 | $72.68 | +23.83% | 16 | Dec 19, 2024 | |
| TFX Teleflex | Reiterates: Hold | n/a | $176.88 | - | 8 | Dec 16, 2024 | |
| SYK Stryker | Maintains: Buy | $409 → $442 | $370.16 | +19.41% | 5 | Dec 12, 2024 | |
| TMDX TransMedics Group | Reiterates: Hold | n/a | $63.90 | - | 6 | Dec 11, 2024 | |
| AORT Artivion | Reiterates: Buy | $34 | $28.55 | +19.09% | 14 | Dec 9, 2024 | |
| HAE Haemonetics | Reiterates: Buy | $112 | $77.41 | +44.68% | 10 | Dec 3, 2024 | |
| BSX Boston Scientific | Reiterates: Hold | n/a | $91.07 | - | 25 | Nov 27, 2024 | |
| LIVN LivaNova | Reiterates: Buy | $75 | $46.75 | +60.43% | 22 | Nov 25, 2024 | |
| MDT Medtronic | Reiterates: Hold | n/a | $81.54 | - | 15 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.76 | +227.10% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4.25 | $2.16 | +96.76% | 15 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $156.89 | - | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $13 | $10.27 | +26.58% | 14 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $8.43 | - | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $22.58 | +86.05% | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $208.79 | - | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $44 | $41.18 | +6.85% | 14 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $43.95 | +47.90% | 11 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $39.68 | - | 19 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $168.31 | - | 21 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $17.15 | +10.79% | 21 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $98.08 | +11.13% | 21 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $240.36 | - | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $97 | $69.91 | +38.75% | 22 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $107.30 | - | 24 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $17.06 | - | 15 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $40 | $30.50 | +31.15% | 28 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $53.65 | - | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $231.79 | - | 13 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $13.27 | +216.50% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $83.47 | -10.15% | 1 | Feb 18, 2021 |
Personalis
Dec 20, 2024
Reiterates: Buy
Price Target: $7.25
Current: $6.09
Upside: +19.05%
Hologic
Dec 19, 2024
Reiterates: Buy
Price Target: $90
Current: $72.68
Upside: +23.83%
Teleflex
Dec 16, 2024
Reiterates: Hold
Price Target: n/a
Current: $176.88
Upside: -
Stryker
Dec 12, 2024
Maintains: Buy
Price Target: $409 → $442
Current: $370.16
Upside: +19.41%
TransMedics Group
Dec 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $63.90
Upside: -
Artivion
Dec 9, 2024
Reiterates: Buy
Price Target: $34
Current: $28.55
Upside: +19.09%
Haemonetics
Dec 3, 2024
Reiterates: Buy
Price Target: $112
Current: $77.41
Upside: +44.68%
Boston Scientific
Nov 27, 2024
Reiterates: Hold
Price Target: n/a
Current: $91.07
Upside: -
LivaNova
Nov 25, 2024
Reiterates: Buy
Price Target: $75
Current: $46.75
Upside: +60.43%
Medtronic
Nov 20, 2024
Reiterates: Hold
Price Target: n/a
Current: $81.54
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $2.5
Current: $0.76
Upside: +227.10%
Nov 13, 2024
Reiterates: Buy
Price Target: $4.25
Current: $2.16
Upside: +96.76%
Nov 13, 2024
Reiterates: Hold
Price Target: n/a
Current: $156.89
Upside: -
Nov 13, 2024
Maintains: Buy
Price Target: $11 → $13
Current: $10.27
Upside: +26.58%
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $8.43
Upside: -
Nov 8, 2024
Reiterates: Buy
Price Target: $42
Current: $22.58
Upside: +86.05%
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $208.79
Upside: -
Nov 7, 2024
Maintains: Buy
Price Target: $37 → $44
Current: $41.18
Upside: +6.85%
Nov 7, 2024
Reiterates: Buy
Price Target: $65
Current: $43.95
Upside: +47.90%
Nov 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $39.68
Upside: -
Nov 6, 2024
Reiterates: Hold
Price Target: n/a
Current: $168.31
Upside: -
Nov 6, 2024
Reiterates: Buy
Price Target: $19
Current: $17.15
Upside: +10.79%
Oct 31, 2024
Reiterates: Buy
Price Target: $109
Current: $98.08
Upside: +11.13%
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $240.36
Upside: -
Oct 31, 2024
Reiterates: Buy
Price Target: $97
Current: $69.91
Upside: +38.75%
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $107.30
Upside: -
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $17.06
Upside: -
Oct 30, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $30.50
Upside: +31.15%
Oct 30, 2024
Reiterates: Hold
Price Target: n/a
Current: $53.65
Upside: -
Oct 25, 2024
Reiterates: Hold
Price Target: n/a
Current: $231.79
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $13.27
Upside: +216.50%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $83.47
Upside: -10.15%